Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy.

Nagl, Laurenz; Horvath, Lena; Salcher, Stefan; Wolf, Dominik; Pircher, Andreas

Nagl, Laurenz; Horvath, Lena; Salcher, Stefan; Wolf, Dominik; Pircher, Andreas.

Affiliation

Nagl L; Department of Haematology and Oncology, Internal Medicine V, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria.
Horvath L; Department of Haematology and Oncology, Internal Medicine V, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria.
Salcher S; Department of Haematology and Oncology, Internal Medicine V, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria.
Wolf D; Department of Haematology and Oncology, Internal Medicine V, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria.
Pircher A; Department of Haematology and Oncology, Internal Medicine V, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria.

Transl Lung Cancer Res ; 12(9): 1959-1965, 2023 Sep 28.

Article de En | MEDLINE | ID: mdl-37854164

Mots clés

Single-cell RNA sequencing (scRNAseq); neo-adjuvant immunotherapy; non-small cell lung cancer (NSCLC); tumor microenvironment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Transl Lung Cancer Res Année: 2023 Type de document: Article Pays d'affiliation: Autriche

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google